Pharmaceutical - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

26 to 50 of 7120 results

Sanofi ousts CEO Viehbacher, despite recent denials

Sanofi ousts CEO Viehbacher, despite recent denials

29-10-2014

Just a day after French pharma major Sanofi denied that the future of its chief executive was under discussion,…

BoardroomFranceManagementPharmaceuticalSanofi

Pfizer beats sales and earnings forecast for the third quarter

Pfizer beats sales and earnings forecast for the third quarter

28-10-2014

US pharma giant Pfizer has beaten the forecasts for both its sales and its earnings for the third quarter…

FinancialLyricaPfizerPharmaceuticalUSAViagra

Recordati reports strong earnings growth for first nine months of 2014

28-10-2014

Italian pharma company Recordati has reported a strong set of financials for the first three-quarters…

FinancialPharmaceuticalRecordati

Russian approval for Norgine/Takeda’s MoviPrep

28-10-2014

Netherlands-headquartered independent drugmaker Norgine says that its partner, Japan’s largest pharma…

Gastro-intestinalsMoviPrepNorginePharmaceuticalRegulationRussiaTakeda Pharmaceutical

Sarepta receives new FDA guidance on data needed for eteplirsen's NDA in Duchenne Muscular Dystrophy

Sarepta receives new FDA guidance on data needed for eteplirsen's NDA in Duchenne Muscular Dystrophy

28-10-2014

Rare and infectious disease specialist Sarepta provided an update on its discussions with the US Food…

CNS DiseaseseteplirsenPharmaceuticalRegulationSarepta TherapeuticsUSA

Bristol-Myers Squibb signs deal with Korean company OliPass

Bristol-Myers Squibb signs deal with Korean company OliPass

28-10-2014

Privately-held Korean biopharmaceutical company OliPass has announced a worldwide strategic alliance…

Bristol-Myers SquibbOliPassPharmaceuticalResearchRest of the World

Elderly UK patients with rare blood cancer receive substandard care

Elderly UK patients with rare blood cancer receive substandard care

28-10-2014

Elderly people in the UK with Myelodysplastic Syndromes (MDS), a rare form of blood cancer, are not being…

Celgene Corp.HealthcareOncologyPharmaceuticalResearchUK

Novartis’ strong third-qtr boosted by sale of Idenix stake

Novartis’ strong third-qtr boosted by sale of Idenix stake

28-10-2014

Swiss pharma major Novartis this morning reported that sales for the third quarter of 2014 rose 4% to…

AlconFinancialNovartisPharmaceuticalSandozSwitzerland

Sanofi's third quarter figures are on track but shares fall on diabetes price competition warning

Sanofi's third quarter figures are on track but shares fall on diabetes price competition warning

28-10-2014

French drug major Sanofi’s third-quarter earnings are in focus, but the company’s shares have plummeted…

FinancialFranceGenzymePharmaceuticalSanofi

Zogenix acquires UK-based Brabant Pharma for up to $130 million

28-10-2014

US CNS focused drugmaker Zogenix says it has acquired Brabant Pharma, a privately-held UK-based pharmaceutical…

BrabafenBrabant PharmaMergers & AcquisitionsNeurologicalPharmaceuticalZogenix

Takeda and Lilly’s fine is reduced in Actos case

Takeda and Lilly’s fine is reduced in Actos case

28-10-2014

A US district court has reduced the damages to be paid by Japan’s largest drugmaker Takeda Pharmaceutical…

ActosDiabetesEli LillyLegalPharmaceuticalTakeda PharmaceuticalUSA

UPDATED: Sanofi chief executive Viehbacher allegedly issues letter to company board defending his position

UPDATED: Sanofi chief executive Viehbacher allegedly issues letter to company board defending his position

28-10-2014

Chris Viehbacher, chief executive of French drug major Sanofi, has urged the company’s board to clarify…

BoardroomFranceLantusPharmaceuticalSanofi

Merck & Co third-qtr disappoints, as earnings plunge

Merck & Co third-qtr disappoints, as earnings plunge

27-10-2014

US pharma giant Merck & Co (NYSE: MRK) posted third-quarter 2014 financial results today, showing that…

FinancialKeytrudaMerck & CoOncologyPharmaceuticalRegulationUSA

Under US pressure, Indian government is getting its act together on IP matters

Under US pressure, Indian government is getting its act together on IP matters

27-10-2014

The pressure from the US government on India seems to be working. With India's intellectual property…

IndiaPatentsPharmaceuticalPoliticsPricing

Allergan posts strong results which provoke reaction from potential suitor Valeant

Allergan posts strong results which provoke reaction from potential suitor Valeant

27-10-2014

Botox maker Allergan has reported strong quarterly results amid an ongoing buyout dispute with Quebecois…

AllerganBotoxBusiness FinancePharmaceuticalUSAValeant

Pfizer to finally drop Remoxy development

27-10-2014

Shares of Durect Corp plunged 42.9% to $0.79 after it revealed that pharma giant Pfizer has decided to…

DurectLicensingNeurologicalPain TherapeuticsPfizerPharmaceuticalPosidurRemoxyUSA

Safety trials under way for GSK and Canadian Public Health Agency's Ebola vaccines

Safety trials under way for GSK and Canadian Public Health Agency's Ebola vaccines

27-10-2014

Safety trials are currently under way in two of the most advanced Ebola candidates, and the World Health…

Antibiotics and Infectious diseasesGSKPharmaceuticalResearchUKUSA

Gastroenterologists underestimate Crohn’s disease and UC in patients

Gastroenterologists underestimate Crohn’s disease and UC in patients

27-10-2014

Most physicians underestimate the severity of moderate or severe inflammatory bowel disease, specifically…

AbbVieGastro-intestinalsPharmaceuticalResearchUSA

Australian PBS listing for Kalydeco and Soliris

Australian PBS listing for Kalydeco and Soliris

27-10-2014

Kalydeco (ivacaftor) and Soliris (eculizumab) – new treatments for cystic fibrosis (CF) and hemolytic…

Alexion PharmaceuticalsAustraliaFinancialHealthcareKalydecoPharmaceuticalRare diseasesSolirisVertex Pharmaceuticals

Russian government to introduce state regulation of drug prices in domestic market

Russian government to introduce state regulation of drug prices in domestic market

27-10-2014

The Russian government is considering introducing state regulation of prices for drugs in the country,…

PharmaceuticalPoliticsPricingRussiaRussian government

Hikma shares slide as FDA issues warning letter over its Portugal injectables plant

Hikma shares slide as FDA issues warning letter over its Portugal injectables plant

27-10-2014

Jordanian drugmaker Hikma has seen its shares fall as a result of a warning from the US Food and Drug…

Hikma PharmaceuticalsHospiraPharmaceuticalPortugalRegulation

CSL buys Novartis’ influenza vaccines business for $275 million

CSL buys Novartis’ influenza vaccines business for $275 million

27-10-2014

Swiss pharma major Novartis has agreed to divest its influenza vaccines business to Australia’s CSL…

Anti-viralsbioCSLCSL LimitedFinancialMergers & AcquisitionsNovartisPharmaceuticalVaccines

Bristol-Myers Squibb third-qtr earnings top expectations

Bristol-Myers Squibb third-qtr earnings top expectations

25-10-2014

US pharma major Bristol-Myers Squib posted a strong set of financials for the third quarter of 2014,…

Bristol-Myers SquibbFinancialPharmaceutical

FDA approves Baxter’s new treatment for rare form of hemophilia

FDA approves Baxter’s new treatment for rare form of hemophilia

25-10-2014

The US Food and Drug Administration on Friday approved Obizur (antihemophilic Factor [recombinant), porcine…

Baxter InternationalHematologyObizurPharmaceuticalRare diseasesUSA

26 to 50 of 7120 results

Parexel

Parexel

Back to top